Načítá se...
Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?
The recent emergence of plasma-derived exosomes as biomarkers of leukemic relapse has introduced the potential for more sensitive non-invasive monitoring of leukemia patients based on the molecular and genetic analysis of the exosome cargo. In principle, the protein, lipid, miRNA, mRNA or DNA profil...
Uloženo v:
| Vydáno v: | Expert Rev Mol Diagn |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400097/ https://ncbi.nlm.nih.gov/pubmed/27043038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737159.2016.1174578 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|